Sweden SimSmoke: The effect of tobacco control policies on smoking and snus prevalence and attributable deaths

European Journal of Public Health

Volumn 24, Issue 3, 2014, Pages 451-458

  Near, Aimee M ^a   Blackman, Kenneth ^b   Currie, Laura M ^c   Levy, David T ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b Econometrica Inc   (United States)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; HEALTH CARE POLICY; HUMAN; MALE; MIDDLE AGED; SMOKELESS TOBACCO; SMOKING; STATISTICAL MODEL; SWEDEN; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH POLICY; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; SMOKING; SWEDEN; TOBACCO, SMOKELESS; YOUNG ADULT;

EID: 84901664469     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckt178     Document Type: Article

References (45)

1. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003;362:847-52.
2. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2011: Warning About the Dangers of Tobacco. Geneva, Switzerland: WHO, 2011.
3. Fagerstrom KO, Schildt EB. Should the European Union lift the ban on snus? Evidence from the Swedish experience. Addiction 2003;98:1191-5. (Pubitemid 37082809)
4. Foulds J, Ramstrom L, Burke M, Fagerstrom K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 2003;12:349-59. (Pubitemid 39452035)
5. Rodu B, Stegmayr B, Nasic S, Asplund K. Impact of smokeless tobacco use on smoking in northern Sweden. J Intern Med 2002;252:398-404. (Pubitemid 36706571)
6. Hatsukami DK, Lemmonds C, Tomar SL. Smokeless tobacco use: Harm reduction or induction approach? Prev Med 2004;38:309-17.
7. Tomar SL. Epidemiologic perspectives on smokeless tobacco marketing and population harm. Am J Prev Med 2007;33:S387-97.
8. Delnevo CD, Wackowski OA, Giovenco DP, et al. Examining market trends in the United States smokeless tobacco use: 2005-2011. Tob Control 2012.
9. MattilaVM, Raisamo S, Pihlajamaki H, et al. Sports activity and the use of cigarettes and snus among young males in Finland in 1999-2010. BMC Public Health 2012;12: 230.
10. SinhaDN, GuptaPC, Ray CS, Singh PK. Prevalence of smokeless tobacco use among adults in WHO South-East Asia. Indian J Cancer 2012;49:342-6.
11. Levy D, de AlmeidaLM, Szklo A. The Brazil SimSmoke policy simulation model: The effect of strong tobacco control policies on smoking prevalence and smokingattributable deaths in amiddle income nation. PLoS Med 2012;9:e1001336.
12. Currie LM, Blackman K, Clancy L, Levy DT. The effect of tobacco control policies on smoking prevalence and smoking-Attributable deaths in Ireland using the IrelandSS simulation model. Tob Control 2013;22:e25-32.
13. Levy D, Gallus S, Blackman K, et al. Italy SimSmoke: The effect of tobacco control policies on smoking prevalence and smoking attributable deaths in Italy. BMC Public Health 2012;12:709.
14. Levy DT, Blackman K, Currie LM, et al. SimSmokeFinn: How far can tobacco control policies move Finland toward tobacco-free 2040 goals? Scand J Public Health 2012;40:544-52.
15. Levy DT, Currie L, Clancy L. Tobacco control policy in the UK: Blueprint for the rest of Europe? Eur J Public Health 2013;23:201-6.
16. Nagelhout GE, Levy DT, Blackman K, et al. The effect of tobacco control policies on smoking prevalence and smoking-Attributable deaths. Findings from the Netherlands SimSmoke Tobacco Control Policy Simulation Model. Addiction 2012;107:407-16.
17. Levy DT, Nikolayev N, Mumford EA. Recent trends in smoking and the role of public policies: Results from the simsmoke tobacco control policy simulation model. Addiction 2005;10:1526-37.
18. Gartner CE, Hall WD, Chapman S, Freeman B. Should the health community promote smokeless tobacco (snus) as aharm reduction measure? PLoS Med 2007;4: E185.
19. MejiaAB, Ling PM, Glantz SA. Quantifying the effects of promoting smokeless tobacco as aharm reduction strategy in the USA. Tob Control 2010;19:297-305.
20. Population and Economic Data2012. Available at: Www.scb.se.
21. West R, DiMarino ME, Gitchell J, McNeill A. Impact of UK policy initiatives on use of medicines to aid smoking cessation. Tob Control 2005;14:166-71. (Pubitemid 40814067)
22. Kaper J, WagenaEJ, Willemsen MC, van Schayck CP. Reimbursement for smoking cessation treatment may double the abstinence rate: Results of arandomized trial. Addiction 2005;100:1012-20. (Pubitemid 40897296)
23. US DHHS. The Health Benefits of Smoking Cessation: Areport of the Surgeon General. AtlantaGeorgia: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Office on Smoking and Health, 1990.
24. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-Term abstinence among untreated smokers. Addiction 2004;99:29-38. (Pubitemid 38142221)
25. Burns D, Garfinkel L, Samet J, editors. Changes in Cigarette-Related Disease Risks and Their Implication for Prevention and Control. Bethesda, MD: National Institutes of Health, National Cancer Institute, 1997.
26. US DHHS. Reducing the Health Consequences of Smoking: 25 Years of Progress: AReport of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1989. Report No.: DHHS Publication No. [CDC] 89-8411.
27. Levy DT, Mumford EA, Cummings KM, et al. The relative risks of alow-nitrosamine smokeless tobacco product compared with smoking cigarettes: Estimates of apanel of experts. Cancer Epidemiol Biomark Prev 2004;13:2035-42. (Pubitemid 40054295)
28. Bask M, Melkersson M. Should one use smokeless tobacco in smoking cessation programs? Arational addiction approach. Eur J Health Econ 2003;4:263-70. (Pubitemid 38081989)
29. Lien Nguyen L, Rosenqvist G, Pekurinen M. Demand for tobacco in Europe. An econometric analysis of 11 countries for the PPACTE project. Helsinki, Finland: National Institute for Health and Welfare, 2012.
30. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008-The MPOWER package. Geneva: World Health Organization; 2008.
31. Ramstrom LM, Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob Control 2006;15:210-4. (Pubitemid 43864877)
32. Aalto-SetalaV, AlarantaA. Effect of deregulation on the prices of nicotine replacement therapy products in Finland. Health Policy 2008;86:355-62.
33. Gallus S, Tramacere I, Pacifici R, et al. Smoking in Italy 2008-2009: Arise in prevalence related to the economic crisis? Prev Med 2011;52:182-3.
34. Ostenson CG, Hilding A, Grill V, Efendic S. High consumption of smokeless tobacco (''snus'') predicts increased risk of type 2 diabetes in a10-year prospective study of middle-Aged Swedish men. Scand J Public Health 2012;40:730-7.
35. Hansson J, Galanti MR, Hergens MP, et al. Use of snus and acute myocardial infarction: Pooled analysis of eight prospective observational studies. Eur J Epidemiol 2012;27:771-9.
36. Wikstrom AK, Cnattingius S, Stephansson O. Maternal use of Swedish snuff (snus) and risk of stillbirth. Epidemiology 2010;21:772-8.
37. BoffettaP, Hecht S, Gray N, et al. Smokeless tobacco and cancer. Lancet Oncol 2008; 9:667-75. (Pubitemid 351878052)
38. Critchley JA, Unal B. Health effects associated with smokeless tobacco: Asystematic review. Thorax 2003;58:435-43. (Pubitemid 36560948)
39. Ayo-Yusuf OA, Burns DM. The complexity of 'harm reduction' with smokeless tobacco as an approach to tobacco control in low-income and middle-income countries. Tob Control 2012;21:245-51.
40. Henley SJ, Connell CJ, Richter P, et al. Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco. Tob Control 2007;16:22-8.
41. Lee PN. The effect on health of switching from cigarettes to snus-Areview. Regul Toxicol Pharmacol 2013;66:1-5.
42. Levy DT, Gitchell JG, ChaloupkaF. The effects of tobacco control policies on smoking rates: Atobacco control scorecard. J Public Health Manag Pract 2004;10: 338-51.
43. Levy DT, Hyland A, Higbee C, et al. The role of public policies in reducing smoking prevalence in California: Results from the CaliforniaTobacco Policy Simulation Model. Health Policy 2007;82:153-66.
44. European Commission. Special Eurobarometer 385: Attitudes of Europeans Towards Tobacco. European Commission, 2012. Available at: Http://eceuropaeu/ public-opinion/archives/ebs/ebs-385-enpdf. Brussels.
45. Zhu SH, Wang JB, Hartman A, et al. Quitting cigarettes completely or switching to smokeless tobacco: Do US datareplicate the Swedish results? Tob Control 2009;18: 82-7.